K. T. Chong

543 total citations
24 papers, 437 citations indexed

About

K. T. Chong is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, K. T. Chong has authored 24 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in K. T. Chong's work include Cytomegalovirus and herpesvirus research (8 papers), Immune Cell Function and Interaction (5 papers) and HIV/AIDS drug development and treatment (5 papers). K. T. Chong is often cited by papers focused on Cytomegalovirus and herpesvirus research (8 papers), Immune Cell Function and Interaction (5 papers) and HIV/AIDS drug development and treatment (5 papers). K. T. Chong collaborates with scholars based in United States, United Kingdom and Vietnam. K. T. Chong's co-authors include Cedric Mims, Roger R. Hinshaw, M M Huston, T. Inada, Ion Gresser, W. Gary Tarpley, Suvit Thaisrivongs, Susan M. Poppe, Martin Markowitz and Robert R. Gorman and has published in prestigious journals such as The Journal of Immunology, Journal of Medicinal Chemistry and The Journal of Infectious Diseases.

In The Last Decade

K. T. Chong

23 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. T. Chong United States 11 189 148 144 130 53 24 437
Eric Guillemard France 12 145 0.8× 133 0.9× 100 0.7× 277 2.1× 247 4.7× 17 718
Yanqin Ren United States 13 198 1.0× 177 1.2× 221 1.5× 258 2.0× 154 2.9× 28 601
Vichai Jirathitikal Ukraine 13 192 1.0× 65 0.4× 188 1.3× 114 0.9× 60 1.1× 31 361
W M Mitchell United States 8 341 1.8× 560 3.8× 221 1.5× 311 2.4× 195 3.7× 8 858
Bakary Diatta Senegal 15 124 0.7× 36 0.2× 84 0.6× 61 0.5× 45 0.8× 41 812
Dominic H. Banda United Kingdom 10 175 0.9× 125 0.8× 181 1.3× 93 0.7× 44 0.8× 15 388
K. M. Ayers United States 8 200 1.1× 117 0.8× 101 0.7× 55 0.4× 132 2.5× 17 445
Hideka Miura Japan 11 266 1.4× 205 1.4× 294 2.0× 117 0.9× 121 2.3× 22 597
Guoyang Liao China 13 206 1.1× 43 0.3× 166 1.2× 81 0.6× 97 1.8× 52 447
Dong P. Han United States 10 385 2.0× 141 1.0× 94 0.7× 126 1.0× 142 2.7× 10 611

Countries citing papers authored by K. T. Chong

Since Specialization
Citations

This map shows the geographic impact of K. T. Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. T. Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. T. Chong more than expected).

Fields of papers citing papers by K. T. Chong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. T. Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. T. Chong. The network helps show where K. T. Chong may publish in the future.

Co-authorship network of co-authors of K. T. Chong

This figure shows the co-authorship network connecting the top 25 collaborators of K. T. Chong. A scholar is included among the top collaborators of K. T. Chong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. T. Chong. K. T. Chong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chong, K. T., et al.. (2025). Investigating a new Dillenia ovata endophytic bacteria to produce antioxidants and anti-diabetes activity in vitro and in vivo. Biotechnology Reports. 48. e00921–e00921. 1 indexed citations
3.
Chong, K. T., et al.. (2025). Study on the toxicity and in vitro and in vivo antidiabetic activities of Miliusa velutina stem bark ethanolic extract. Phytomedicine Plus. 5(4). 100879–100879. 1 indexed citations
4.
Trang, Đái Thị Xuân, et al.. (2025). Optimizing extraction of antioxidant-enriched Dillenia ovata stem bark and evaluating its antidiabetic activities in vitro and in vivo. Current Research in Biotechnology. 10. 100348–100348.
6.
Chong, K. T., et al.. (2015). Sero-prevalence study of IgE responses to allergens from Malaysian house dust (HDM) and storage mites (SM).. PubMed. 32(3). 524–39. 4 indexed citations
7.
Chong, K. T., et al.. (1997). In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates. Antimicrobial Agents and Chemotherapy. 41(11). 2367–2373. 33 indexed citations
9.
Islam, Imadul, K. T. Chong, T. J. MCQUADE, et al.. (1994). Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitors. Journal of Medicinal Chemistry. 37(2). 293–304. 10 indexed citations
11.
Ho, Rodney J. Y., K. T. Chong, & T. C. Merigan. (1991). Antiviral activity and dose optimum of recombinant macrophage colony-stimulating factor on herpes simplex genitalis in guinea pigs. The Journal of Immunology. 146(10). 3578–3582. 7 indexed citations
12.
Chong, K. T. & M M Huston. (1987). Implications of Endotoxin Contamination in the Evaluation of Antibodies to Lipopolysaccharides in a Murine Model of Gram-Negative Sepsis. The Journal of Infectious Diseases. 156(5). 713–719. 29 indexed citations
13.
Chong, K. T.. (1987). Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria. Infection and Immunity. 55(3). 668–673. 50 indexed citations
14.
Chong, K. T. & Cedric Mims. (1984). Effects of pregnant mouse serum and pregnancy hormones on the replicationin vitro of murine cytomegalovirus. Archives of Virology. 82(3-4). 223–231. 6 indexed citations
15.
Chong, K. T. & Cedric Mims. (1983). Antigen-specific Suppression of Delayed Type Hypersensitivity to Murine Cytomegalovirus in MCMV-infected Mice. Journal of General Virology. 64(11). 2433–2439. 7 indexed citations
16.
Chong, K. T. & Cedric Mims. (1983). Rash produced by mouse cytomegalovirus. Infection and Immunity. 41(1). 352–357. 6 indexed citations
17.
Chong, K. T., Ion Gresser, & Cedric Mims. (1983). Interferon as a Defence Mechanism in Mouse Cytomegalovirus Infection. Journal of General Virology. 64(2). 461–464. 33 indexed citations
18.
Chong, K. T. & Cedric Mims. (1982). Delayed hypersensitivity to murine cytomegalovirus and its depression during pregnancy. Infection and Immunity. 37(1). 54–59. 12 indexed citations
19.
Chong, K. T. & Cedric Mims. (1981). Murine Cytomegalovirus Particle Types in Relation to Sources of Virus and Pathogenicity. Journal of General Virology. 57(2). 415–419. 18 indexed citations
20.
Chong, K. T., et al.. (1981). Neutralization of different strains of murine cytomegalovirus (MCMV)-effect ofin vitro passage. Archives of Virology. 69(2). 95–104. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026